RichLegg Biomea Fusion company background Biomea Fusion (NASDAQ:BMEA) is a clinical-stage US biotechnology company developing unique covalent small molecule inhibitors. BMEA has three novel irreversible inhibitor candidates in clinical development, a) lead BMF-219, a menin […]
phototechno/iStock via Getty Images RIVN Delivers After All We previously covered Rivian Automotive (NASDAQ:RIVN) in May 2023, ending the article with a speculative buy rating, thanks to the improved risk reward ratio with the stock […]
da-kuk This article’s purpose is to compare these two financial stocks which are taking part in the banking sector recovery. First, I will assess the nature of Buffett and Burry’s Investments. Next, I will compare […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.